Pharmacotherapy of allergic rhinitis: current options and future perspectives.

@article{Ridolo2014PharmacotherapyOA,
  title={Pharmacotherapy of allergic rhinitis: current options and future perspectives.},
  author={Erminia Ridolo and Marcello Montagni and Valerie Melli and Fulvio Braido and Cristoforo Incorvaia and Giorgio Walter Canonica},
  journal={Expert opinion on pharmacotherapy},
  year={2014},
  volume={15 1},
  pages={73-83}
}
INTRODUCTION Allergic rhinitis (AR) is a very common disease, caused by environmental aeroallergen, and clinically expressed by sneezing, nasal itching, rhinorrhea and obstruction. It is often considered a mild illness, but actually it has a significant individual and social burden. The management of AR is based on allergen avoidance, pharmacological treatment and allergen specific immunotherapy. AREAS COVERED In this article, the authors summarize the current status of pharmacotherapy of AR… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 13 times. VIEW TWEETS

Similar Papers

Loading similar papers…